Pneumagen Raises £8M To Accelerate Phase 2 Clinical Development Of Neumifil For The Prevention & Treatment Of Viral Respiratory Tract Infections
Amount Raised
£8 Million
Round Type
Funding Round
St. AndrewsHealth CareDescription
St Andrews, UK – 1st June 2023 - Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs), today announced that it has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil in Chronic Obstructive Pulmonary Disease (COPD) patients suffering from virus induced exacerbations.
Who else raised in Health Care around the same time
Companies in the same sectors as Pneumagen that raised within 45 days of this round, from Fundz verified event records.
- Piur Imaging raised $5.5M (Funding Round) on July 15, 2023.
- INTRINSIC THERAPEUTICS raised $5.5M on July 14, 2023.
- Family First raised $11M on July 14, 2023.
- CurvaFix raised $39M (Series C) on July 14, 2023.
- Imagen Dental Partners raised $568K (Seed) on July 14, 2023.
- Petros Pharmaceuticals, Inc. raised $30M on July 13, 2023.
Who to call at Pneumagen, and when
A new round usually means Pneumagen is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pneumagen raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pneumagen, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pneumagen. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pneumagen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pneumagen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.